NLRP3 and depressive symptom measurement: Clinical evidence has demonstrated significantly higher concentrations of inflammatory cytokines, such as IL-1β, IL-6 and TNF-α activated by NLRP3 in the cerebrospinal fluid and serum of patients with depression compared to non-depressed individuals [26].